Sip2, an N-Myristoylated beta  Subunit of Snf1 Kinase, Regulates Aging in Saccharomyces cerevisiae by Affecting Cellular Histone Kinase Activity, Recombination at rDNA Loci, and Silencing*

Stephen S. Lin, Jill K. Manchester, and Jeffrey I. GordonDagger

From the Department of Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, Missouri 63110

Received for publication, December 17, 2002, and in revised form, January 23, 2003

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Saccharomyces cerevisiae has evolved a number of mechanisms for sensing glucose. In the present study we examine the mechanism by which one of these pathways, involving Snf1, regulates cellular aging. Snf1 is a heterotrimer composed of a catalytic alpha  subunit (Snf1p) that phosphorylates target proteins at Ser/Thr residues, an activating gamma  subunit (Snf4p), and a beta  subunit (Sip1p, Sip2p, or Gal83). We previously showed that forced expression of Snf1p or loss of Sip2p, but not the other beta  subunits, causes accelerated aging, while removal of Snf4p extends life span (Ashrafi, K., Lin, S. S., Manchester, J. K., and Gordon, J. I. (2000) Genes Dev. 14, 1872-1885). We now demonstrate that in wild type cells, there is an age-associated shift in Sip2p from the plasma membrane to the cytoplasm, a prominent redistribution of Snf4p from the plasma membrane to the nucleus, a modest increase in nuclear Snf1p, and a concomitant increase in cellular Snf1 histone H3 kinase activity. Covalent attachment of myristate to the N-terminal Gly of Sip2p is essential for normal cellular life span. When plasma membrane association of Sip2p is abolished by a mutation that blocks its N-myristoylation, Snf4p is shifted to the nucleus. Rapidly aging sip2Delta cells have higher levels of histone H3 kinase activity than their generation-matched isogenic wild type counterparts. Increased Snf1 activity is associated with augmented recombination at rDNA loci, plus desilencing at sites affected by Snf1-catalyzed Ser10 phosphorylation of histone H3 (the INO1 promoter plus targets of the transcription factor Adr1p). The rapid-aging phenotype of sip2Delta cells is fully rescued by blocking recombination at rDNA loci with a fob1Delta allele; rescue is not accompanied by amelioration of an age-associated shift toward gluconeogenesis and glucose storage. Together, these findings suggest that Sip2p acts as a negative regulator of nuclear Snf1 activity in young cells by sequestering its activating gamma  subunit at the plasma membrane and that loss of Sip2p from the plasma membrane to the cytoplasm in aging cells facilities Snf4p entry into the nucleus so that Snf1 can modify chromatin structure.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Saccharomyces cerevisiae is a unicellular model for studying the molecular mechanisms of aging. Mother yeast cells undergo replicative senescence, with different strains having characteristic mean and maximum life spans (1). Senescence is associated with a number of cellular and molecular phenotypes. Progressive sterility arises from the loss of silencing at HM loci (2). This loss of silencing is accompanied by a redistribution of Sir3p, a component of the Sir-silencing complex, from HM loci and telomeres to the nucleolus (3). Homologous recombination at rDNA loci liberates an extrachromosomal rDNA circle (ERC)1 that contains an autonomously replicating sequence (4). With each round of cell division, replicated ERCs segregate to the mother rather than to daughter, leading to an exponential increase in cellular ERC concentrations over successive generations.

ERC formation is thought to be a mediator as well as a marker of aging. Exponential increases in ERCs likely leads to titration of critical DNA repair/replication and transcription factors (5). Fob1p specifically acts at the rDNA locus, where it supports opening of the replication bubble (6) and binds to HOT1 sites, thereby promoting homologous recombination. fob1Delta alleles block rDNA formation and extend life span >= 20% beyond wild type (wt) (4).

Mutations, such as sir2Delta , that reduce rDNA silencing are associated with increased rates of recombination and accelerated aging (7, 8). The importance of the regulation of silencing in aging is also emphasized by the findings that Sir2p is a NAD+-dependent histone deacetylase (9) and that NAD+ production leads to Sir2p-dependent life span extension (10). To catalyze deacetylation, Sir2p converts NAD+ to nicotinamide and O-acetyl-ADP-ribose (11, 12). Yeast grown on medium containing nicotinamide, a noncompetitive Sir2p inhibitor, display Sir2p-dependent rDNA desilencing and a shortened life span (13).

The effects of NAD+ on Sir2p provide a potential link between aging and cellular glucose/energy metabolism. They also raise the question of how aging affects upstream elements in glucose-sensing pathways and whether such pathways affect replicative life span.

S. cerevisiae has evolved elaborate and elegant mechanisms for sensing environmental glucose, its principal nutrient source. A major glucose-sensing pathway involves Snf1, the homolog of mammalian AMP-activated protein kinase (AMPK) that is involved in regulating cellular stress responses (14). Snf1 is a heterotrimeric complex composed of alpha , beta , and gamma  subunits (15, 16). The complex contains one of three beta  subunits, Sip1p, Sip2p, or Gal83p, that binds to the catalytic alpha  subunit, Snf1p (a serine/threonine kinase) (17). The gamma  subunit, Snf4p (18), binds to an autoinhibitory domain of Snf1p, releasing its catalytic domain. Phosphorylation of Thr210 in the Snf1p C-terminal activation loop also promotes kinase activity (19), although the Snf1p kinase kinase has yet to be identified.

The Snf1 complex responds to glucose starvation by catalyzing phosphorylation of a number of target proteins, including transcriptional regulators of genes involved in alternative carbon source utilization, gluconeogenesis, and respiration (20). For example, when glucose is limiting, Mig1p is hyperphosphorylated by Snf1p causing it to translocate from the nucleus to the cytoplasm and derepress gene expression (21).

We have reported that forced expression of SNF1, or loss of Sip2p (sip2Delta ), produces an accelerated aging phenotype (i.e. a shortened replicative life span accompanied by progressive sterility, redistribution of Sir3p from telomeres and HM loci to the nucleolus, and increased ERC accumulation) (22). The effect of Sip2p on aging is unique among Snf1 beta -subunits: gal83Delta has no effect on life span and sip1Delta produces a modest (<20%) reduction in life span but without the other manifestations of accelerated aging. Loss of the gamma  subunit (snf4Delta ) produces a 20% increase in life span (22). Together, these results implied that increased Snf1 activity promotes rapid aging and that Sip2p functions to repress Snf1p activity. Two additional observations supported this hypothesis: (i) Mig1p undergoes progressive redistribution from the nucleus to the cytoplasm as wt cells and sip2Delta cells age, and (ii) the rapid-aging phenotype produced by sip2Delta is completely rescued by snf4Delta (22). However, our studies indicated that the effects of Snf1 activation on life span must extend beyond its phosphorylation of Mig1p since mig1Delta cells did not undergo rapid aging (22).

Follow-up DNA microarray analysis revealed that a number of Mig1p-repressed genes were derepressed in generation 7-8 wt and sip2Delta cells compared with their generation 0-1 counterparts (23). The analysis also identified a number of other genes with age-associated changes in their expression that are not regulated by Mig1p but are involved in various aspects of cellular energy metabolism. Direct biochemical analysis of cellular metabolism established that aging in wt cells is accompanied by a shift away from glycolysis and toward gluconeogenesis and energy storage (23). This shift is deferred in snf4Delta cells and accelerated in isogenic sip2Delta strains leading to a proposal that the shift toward glucose and energy storage may be a mediator as well as a marker of aging (23).

Studies of the promoter region of INO1 (inositol-1-phosphate synthase) showed that Snf1 phosphorylates histone H3 at Ser10, which facilitates acetylation at Lys14 by Gcn5p (histone acetyltransferase) (24). These findings in young cells raise the possibility that Snf1 could promote aging by modifying chromatin structure at specific genomic loci. Therefore, in the current study, we have explored the mechanisms by which sip2Delta operates through Snf1 to regulate aging and chromatin structure. We show that covalent addition of myristate, a 14 carbon-saturated fatty acid, to the N-terminal Gly residue of Sip2p is essential for its localization to the plasma membrane and its contribution to a normal generational life span. As yeast cells age, Snf4p is redistributed from the plasma membrane to the nucleus. This redistribution, which is promoted by sip2Delta , is accompanied by increased cellular Snf1p histone H3 kinase activity, desilencing, and increased recombination at rDNA loci with increased ERC formation. The rapid-aging phenotype of sip2Delta cells is completely rescued by removing Fob1p, an essential mediator of ERC formation. Together, our results suggest that the glucose-sensing Snf1 pathway regulates aging by affecting chromatin structure and genomic stability.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Strains-- The isogenic strains YB332 (wt; S288CMATaNMT1ura3-52his3Delta 200ade2-101lys2-801leu2-3,112), YB810 (sip2::HIS3), and YB614 (snf4::HIS3) are described in Ref. 22. Additional strains were constructed using standard methods (25) and are listed in Table I.


                              
View this table:
[in this window]
[in a new window]
 
Table I
Yeast strains

Life Span Determination-- Micromanipulation assays (26) were used to define the number of divisions that individual virgin mother yeast cells undergo on YPD (1% yeast extract, 2% peptone, 2% dextrose) agar plates at 24 °C (n = >= 40 mothers/genotype/experiment; n = two to three independent experiments/strain). Wt cells were used as reference controls in each experiment. The statistical significance of observed differences in life spans was evaluated using the nonparametric Wilcoxen signed rank test.

Isolation of Young and Older Yeast Cell Populations-- When the surface proteins of a mother yeast cell are labeled with biotin, the daughter does not inherit the biotinylated proteins because its surface is generated de novo at the budding site (2). This allows mothers to be isolated from their progeny by streptavidin-magnetic bead sorting. The protocol used to obtain sorted populations of generation 0-1 and generation 7-8 or 9-10 cells is described in Ref. 2. Note that generation 0-1 refers to the population of cells that remains after old cells are removed by sorting; on average, 50% of this population will be composed of newly formed daughters, while 25% are mothers that have undergone a single cell division.

Defining the Intracellular Localization of Snf1, Snf4, and Sip2-- Isogenic wt and sip2Delta cells were transformed with one of the following four CEN plasmids: pOV84 (Snf1p-green fluorescent protein (GFP fusion)), pOV76 (Snf4p-GFP), pRT9 (Sip2p-GFP) (27), (gifts from Marian Carlson, Columbia Univ.), or pBB507 (Sip2p (Gly1 right-arrow Ala)-GFP). Generation 0-1 and 7-8 cells were recovered by magnetic bead sorting from cultures grown in synthetic medium containing 2% glucose, suspended in a solution of 8 mM potassium phosphate buffer, pH 7.0, 4 mM MgSO4, 26 mM ammonium sulfate, and 2% glucose, incubated for 5 min at 24 °C, washed twice in the same solution, and then examined under a Zeiss Axioplan 2 microscope (n = two to three independent experiments).

Snf1p Histone H3 Kinase Assay-- Snf1p contains an N-terminal domain with 13 histidine residues (His18-His30), facilitating its purification from cell lysates by Ni-NTA-agarose affinity chromatography (20). Generation 0-1 and 7-8 isogenic wt and sip2Delta cells (2-5 × 107; defined by hemocytometer counts) were recovered from a mid-log phase YPD culture by magnetic bead sorting, frozen in liquid N2, freeze-dried, and then incubated for 5 min at 1 °C in 1 ml of extraction buffer (20 mM potassium phosphate buffer, pH 7.4, 0.02% bovine serum albumin, 0.5 mM EDTA, 5 mM beta -mercaptoethanol, 25% glycerol, 0.5% Triton X-100, and 50 mM potassium fluoride). The resulting cell lysate was added directly to 1 ml of Ni-NTA-agarose (Qiagen) pre-equilibrated with 5 ml of buffer A (0.3 M NaCl, 75 mM sodium phosphate buffer, pH 7.0, and 50 mM potassium fluoride). The mixture was incubated for 60 min at 4 °C. The resin was then washed with buffer A (three cycles, 5 ml/cycle) and poured into a column, and Snf1 activity was eluted with 1 ml of buffer A supplemented with 50 mM imidazole. Eluted proteins were concentrated to 0.1-0.2 µg/ml (Centricon 30 filter column).

The scheme for measuring histone H3 kinase activity in the 50-mM imidazole fraction is outlined in Fig. 1A. A 0.5-µl aliquot of the 50-mM imidazole-eluted fraction (containing 50-100 ng of protein) was added to 0.5 µl of kinase reagent (50 mM imidazole-HCl, pH 6.7, 0.04% bovine serum albumin, 4 mM MgCl2, 100 mM potassium fluoride, 0.5 mM phosphoenolpyruvate (Sigma), 0.5 mM ATP, 40 µg/ml rabbit muscle pyruvate kinase (specific activity = 200 units/mg; Roche Molecular Biochemicals)) containing 0.5 mM of a previously published histone H3 peptide substrate for Snf1p (24) (ARTKQTARKSTGGKAPRKQLASKAARC; Biomolecules Midwest, Waterloo, IL). The 1-µl mixture was incubated for 60 min at 20 °C. The reaction was stopped with 0.5 µl of 0.2 M HCl (10 min, 20 °C), and a second reaction initiated by adding 0.5 µl of a solution containing 200 mM imidazole-HCl, pH 7.0, 80 mM NaOH, 0.08% bovine serum albumin, 20 mM EDTA, 0.2 mM NADH, 8 µg/ml beef heart lactate dehydrogenase (specific activity = 500 units/mg; Sigma). The mixture was incubated for an additional 10 min at 20 °C. 0.5 µl of 0.4 M HCl was then introduced to destroy any excess NADH.

To detect the NAD+ product generated from the Snf1p histone H3 kinase reaction (Fig. 1A), the product had to be amplified through a series of coupled reactions (for details of this well established analytic method, see Refs. 23 and 28). Five thousand cycles of amplification were achieved by adding 0.5 µl of the reaction mixture to 0.1 ml of NAD cycling reagent (100 mM Tris-HCl, pH 8.1, 2 mM oxaloacetic acid, 2 mM beta -mercaptoethanol, 0.3 M ethanol, 0.02% bovine serum albumin, 12.5 µg/ml alcohol dehydrogenase (specific activity = 300 units/mg; Sigma), 1.2 µg/ml malic dehydrogenase (specific activity = 3000 units/mg; Sigma)) and incubating the solution for 60 min at 24 °C. The reaction was terminated (100 °C; 5 min), cooled to room temperature, and 1 ml of malate indicator reagent (50 mM amino-methylpropanol (pH 9.9), 5 mM L-glutamate (pH 9.9), 0.2 mM NAD+, 5 µg/ml malic dehydrogenase (3000 units/mg; Sigma), and 2 µg/ml glutamate oxaloacetate transaminase (200 units/mg; Roche Molecular Biochemicals)) was added to convert the cycled product to NADH (23).


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 1.   Snf1p kinase assay. A, schematic outline of assay. B, dependence of the assay on time and amount of input Snf1p, recovered by Ni-NTA-agarose chromatography from generation 0-1 wt cell lysates. Two 26-residue peptides were assayed in parallel: one contained the Ser10 phosphorylation site of histone H3 (1ARTKQTARKSTGGKAPRKQLASKAARC); the other was a prephosphorylated synthetic derivative (1ARTKQTARKpSTGGKAPRKQLASKAARC) that was used to define specificity of the Snf1p kinase reaction for Ser10. All assays were done in duplicate. The results shown are representative of two independent experiments using different Snf1p preparations. C, double reciprocal plot determination of the Km of the histone H3 peptide substrate.

Several types of reference standards and controls were run in parallel with the experimental reaction. NAD+ standards were always added at the cycling step into cycling reagent alone. Known amounts of malate was included as another reference control. A minus peptide reaction, and a reaction containing a synthetic phosphorylated histone H3 peptide (1ARTKQTARKpSTGGKAPRKQLASKAARC; Biomolecules Midwest) were used to confirm Ser10-specific phosphorylation. (Note that we were unable to detect Snf1p-catalyzed phosphorylation of the H3 peptide using unfractionated whole cell lysates due to the high background signal, as defined with the histone H3 peptide and its phospho-Ser10 derivative).

ERC Analysis-- DNA was prepared from sorted generation 0-1 and 7-8 cells according to Sinclair and Guarente (5) with one exception: no zymolyase was used in the first step; instead, 0.5 ml of sorbitol solution (0.9 M sorbitol, 0.1 M Tris, pH 8.0, 0.1 M EDTA) was added to freeze-dried cell pellets. Purified DNA was fractionated by electrophoresis through 0.7% agarose containing TAE buffer (40 mM Tris acetate, 1 mM EDTA, pH 7.5). Following capillary transfer to GeneScreen Plus (Invitrogen), blots were probed with a 32P-labeled, 2.8-kB EcoRI fragment containing rDNA sequences from pNL47 (5).

Recombination and Silencing Assays-- Assays for recombination and silencing used PSY316a strains containing ADE2 integrated into RDN1 or telomeric loci (Table I). To measure recombination rates, cells with a 2µ plasmid containing SNF1 under the control of its own promoter (21), or the empty YEp24 vector, were spread onto YPD/agar plates and incubated for 30 °C for 3 days. Recombination frequency was defined as the number of half-sectored red/white colonies divided by the total number of colonies (n = >104 colony scored/strain; n = four independent experiments). To measure silencing, cells were grown on synthetic complete medium. Individual colonies were picked and transferred to 1 ml of PBS. Cells were serially diluted in PBS and plated onto synthetic medium minus adenine. Plates were incubated for 20 h at 30 °C, and the number of viable colonies scored per dilution.

Microanalytic Biochemical Assays-- Levels of fructose 1,6-bisphosphatase, glycogen, NAD+, ATP, and AMP were assayed in young and old isogenic wt, sip2Delta , fob1Delta , and sip2Delta /fob1Delta cells using pyridine nucleotide-based enzyme-cycling methods. These previously described, sensitive methods permit analysis of enzymes and metabolites in a single sample of 106 sorted cells (23, 28, 29).

Gene Expression Profiles of Young and Old Cells-- Details of this analysis are provided in an earlier publication (23). Briefly, RNAs were prepared from sorted generation 0-1 and 7-8 wt and sip2Delta cells (5 × 107 cells/sort; n = three independent sorts from separate cultures). Equivalent amounts of RNA from generation-matched cells from each sort of a given strain were pooled. Two cRNA targets were independently prepared from each RNA pool, and each cRNA used to interrogate a high density oligonucleotide-based Ye98 GeneChip (23). Pairwise comparisons of expression levels in old versus young cells were performed for both strains using proprietary GeneChip software (Affymetrix).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Age-associated Changes in the Intracellular Distribution of Components of the Snf1p Kinase Complex-- We began our analysis of the mechanisms by which Snf1 affects aging by characterizing the intracellular distributions of its Snf1p alpha  subunit, Sip2p beta  subunit, and Snf4p gamma  subunit in generation 0-1 and 9-10 wt cells that had been grown in synthetic medium containing 2% glucose. Snf1p, Snf4p, and Sip2p with C-terminal GFP reporters were all expressed from low copy CEN plasmids under the control of their own promoters. Previous studies have shown that each of these constructs fully rescues the growth phenotypes produced by the null alleles of the corresponding gene in log phase cells (27). This rescue suggests that the GFP fusions accurately represent the trafficking patterns of the wild type proteins.

The majority of Snf1p-GFP is present in the cytoplasm of young (generation 0-1) cells, with a small fraction appearing in the nucleus. By generation 9-10, there is a modest shift in the protein to the nucleus (Fig. 2A). Sip2p-GFP is largely associated with the plasma membrane in young cells. As cells age, there is increased representation in the cytoplasm of a subset of cells (Fig. 2B). Like Sip2p-GFP, Snf4p-GFP is plasma membrane-bound in young cells, although there is also cytoplasmic localization. With age, Snf4p-GFP shifts away from the plasma membrane to the cytoplasm and nucleus (Fig. 2C).


View larger version (49K):
[in this window]
[in a new window]
 
Fig. 2.   Localization of Snf1 complex subunits in young and aged cells. A-D, Wt cells containing a CEN plasmid encoding either Snf1p-GFP, Sip2p-GFP, Snf4p-GFP, or a N-myristoylation-defective Sip2p (Gly1 right-arrow Ala) mutant were grown in synthetic medium containing 2% glucose, and generation 0-1 and/or 9-10 cells isolated by magnetic bead sorting. Note that with increasing age, Snf4p is redistributed from the plasma membrane to the nucleus. Loss of the myristoyl moiety from Sip2p abrogates its ability to affiliate with the plasma membrane. E, studies of sip2Delta cells showing the effect of loss of myristoylSip2p on Snf4p localization in generation 0-1 cells. Comparison with C reveals that Sip2p is a key contributor to the plasma membrane association of Snf4p. Bars, 2.5 µm.

Our previous in vitro studies had established that Sip2p is substrate for myristoyl-CoA:protein N-myristoyltransferase (Nmt1p) (30). Nmt1p catalyzes the transfer of tetradecanoate (myristate; C14:0) from CoA to the N-terminal Gly1 residues of ~70 yeast proteins (30). This modification occurs co-translationally and appears to be irreversible. N-Myristoylation is known to promote protein-membrane and protein-protein interactions that typically involve components of signal transduction cascades (e.g. kinases, kinase substrates, protein phosphatases, and alpha  subunits of heterotrimeric G proteins; reviewed in Ref. 31).

We examined the contribution of N-myristoylation to the plasma membrane targeting of Sip2p. Substituting the Gly1 of Nmt1p substrates with Ala is sufficient to completely block their N-myristoylation (31). Therefore, we mutated Gly1 of Sip2-GFP to Ala, yielding Sip2G1A-GFP. Studies of generation 0-1 wt cells containing a sip2G1A-GFP CEN episome revealed that loss of the myristoyl moiety changed the protein distribution from the plasma membrane to the cytoplasm and nucleus (Fig. 2D).

Comparison of isogenic generation 0-1 wt and sip2Delta cells containing SNF4-GFP or SNF1-GFP CEN episomes disclosed that in the absence of Sip2p, Snf4p was redistributed from the plasma membrane to the cytoplasm and nucleus (Fig. 2E). The distribution of Snf1p was not affected; it remained principally cytoplasmic with a small fraction in the nucleus (data not shown). Based on these findings, we conclude that N-myristoylation of Sip2p is essential for its plasma membrane localization, as well as the plasma membrane localization of Snf4p, and that loss of Sip2p from the plasma membrane allowed Snf4p to enter the nucleus.

We next assessed the impact of N-myristoylation of Sip2p on cellular life span. To do so, CEN episomes containing SIP2 or sip2-G1A were introduced into sip2Delta cells. Wt cells as well as sip2Delta cells with an empty CEN episome served as controls. The SIP2 episome completely rescued the shortened generational life span of sip2Delta cells, while sip2G1A, or the vector alone, had no effect (Fig. 3). Thus, N-myristoylation of Sip2p is required for a normal cellular life span.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 3.   Genetic evidence that N-myristoylation of Sip2p is essential for a normal cellular life span. Life spans of sip2Delta cells containing SIP2 or sip2G1A CEN episomes or the empty vector.

Snf1p-directed Histone H3 Kinase Activity Increases in Aging Wt Cells-- To further define the effects of the observed age-associated redistribution of Snf1 complex components to the nucleus, we developed a sensitive in vitro assay to measure Snf1p histone H3 kinase activity in small numbers (~3 × 104) of sorted generation 0-1 and 7-8 wt and sip2Delta cells. Snf1p can catalyze phosphorylation of Ser10 in a 26-amino acid peptide acceptor representing Ala1-Arg26 of S. cerevisiae histone H3 (ARTKQTARKSTGGKAPRKQLASKAARC; Ref. 24). Our assay was linear with time, and with H3 peptide substrate and input protein concentration (Fig. 1B). The specificity of the Snf1 kinase for Ser10 was confirmed in control reactions that either contained no peptide, or the preformed phosphopeptide (1ARTKQTARKpSTGGKAPRKQLASKAARC; e.g. Fig. 1B) The Km for the H3 peptide (163 µM; Fig. 1C) is significantly better than the Km of a peptide that contains the phosphorylation site of another known Snf1p target, acetyl-CoA carboxylase (HMRSAMSGLHLVKRR; Km = 1000 µM).

The in vitro assay disclosed that Snf1 histone H3 kinase activity was 2-fold higher in generation 7-8 compared generation 0-1 wt cells (p < 0.05; Fig. 4A). Moreover, the activity in young (generation 0-1) sip2Delta cells was up to 3-fold higher than young wt cells. Levels did not increase significantly as sip2Delta cells aged to generation 7-8 (Fig. 4A).


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 4.   Effects of aging on Snf1-catalyzed Ser10 phosphorylation of histone H3. A, histone H3 kinase assay of Snf1p recovered from generation 0-1 and 7-8 wt and sip2Delta cell lysates. n, number of determinations on independently sorted cell populations. Mean values ± S.D. are plotted. An asterisk indicates that kinase activity is significantly different (p < 0.05, Students' t test) compared with generation 0-1 wt cells. B, ATP and AMP concentrations in generation 0-1 and 7-8 cells. Mean values ± S.E. are plotted (n = three to six independent determinations, each in duplicate).

Like its mammalian homolog AMPK, Snf1 may be activated by the low ATP/AMP ratios that result from impaired glycolytic activity during starvation (20). However, the difference in histone H3 kinase levels observed between wt and sip2Delta cells was not attributable to differences in their ATP:AMP ratios (Fig. 4B).

These results establish that the redistribution of Snf1 complex components to the nucleus in aging wt cells and the shift in Snf1p/Snf4p to the nucleus in young cells lacking plasma membrane-associated N-myristoylated Sip2p are associated with increased cellular levels of histone H3 kinase activity. Together with the Snf1 subunit localization data presented above, our findings indicate that (i) the Sip2p beta  subunit functions as a negative regulator of nuclear Snf1 activity in young cells by sequestering its activating Snf4p gamma  subunit at the plasma membrane and (ii) this inhibition is overcome in aging cells through a shuttling of Sip2p from the plasma membrane to the cytoplasm and a concomitant rise in nuclear Snf4p/ Snf1p.

Snf1p Promotes Recombination and Desilencing-- We next examined whether the observed in vitro changes in Snf1p-catalyzed histone H3 kinase activity were accompanied by in vivo alterations in chromatin structure at rDNA loci. Fob1p regulates recombination at rDNA repeats (6), and fob1Delta produces decreased ERC formation and increased replicative life span in wt strains (4). Therefore, we introduced a fob1Delta allele into sip2Delta cells. Removal of Fob1p not only rescued the shortened generational life span of sip2Delta cells, but extended it beyond wt to levels observed with the isogenic fob1Delta strain (125% of wt; Fig. 5A). ERC levels in generation 7-8 sip2Delta fob1Delta cells were also equivalent to that of fob1Delta alone (Fig. 5B). Finally, the life span of the snf4Delta fob1Delta strain did not extend beyond fob1Delta alone (data not shown). These findings indicate the Snf1 pathway is a regulator of ERC formation and that recombination at rDNA loci is an essential component of the rapid-aging phenotype observed in sip2Delta cells.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 5.   Deletion of FOB1 rescues the rapid-aging phenotype of sip2Delta cells. A, life spans of the isogenic wt, sip2Delta , fob1Delta , and sip2Delta fob1Delta strains. B, Southern blot analysis of ERC levels in sorted generation 0-1 and 7-8 cells. Blots were probed with a radiolabeled rDNA probe.

Additional in vivo proof that Snf1p itself is a positive regulator of recombination at rDNA loci came from an independent assay of recombination in generation 0-1 wt cells with a high copy 2µ plasmid containing SNF1 under the control of its own promoter. Recombination was monitored by scoring loss of an integrated ADE2 reporter from the rDNA locus (10). Recombination causes ADE2 to become a part of the ERC. Since ERCs only segregate to the mother, all daughter cells will appear red on YPD medium due to their adenine auxotrophy. Loss of the ADE2 marker after the first cell division results in a "half-sectored" colony, i.e. one that is half-red and half-white. Based on this assay, wt cells with the SNF1-containing episome have a statistically significant (p < 0.05) 4-fold higher rate of recombination at the rDNA locus compared to cells with the empty 2µ vector (Fig. 6A).


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 6.   Forced expression of SNF1 causes desilencing and increased recombination at the rDNA locus. A, rDNA recombination assay. The rDNA:ADE2 strain was plated on YPD/agar at a dilution that allowed individual colonies to be scored for red/white sectoring. Recombination frequency was defined as the ratio of half-sectored red colonies to total colonies. B, a high-copy SNF1-containing episome or the empty 2µ vector was introduced into PSY316a cells with ADE2 placed at a rDNA locus. Cells were serially diluted and spotted onto synthetic medium with or without adenine.

Further evidence that Snf1p affects chromatin structure at the rDNA locus came from a silencing assay. This assay is based on the finding that loss of silencing at rDNA containing an ADE2 marker results in increased expression of the integrated gene (7) and faster growth on synthetic complete medium lacking adenine. Forced expression of Snf1p promoted growth of wt cells on synthetic complete medium minus adenine, while control experiments showed that there was no difference in growth on medium with adenine (Fig. 6B). A similar result was obtained with a strain that contained ADE2 integrated into a telomeric region (data not shown).

Results obtained from a GeneChip analysis of generation 0-1 and 7-8 isogenic wt and sip2Delta cells provided a final set of observations supporting the notion that age-associated increases in Snf1p-mediated histone H3 phosphorylation/acetylation is accompanied by changes in chromatin structure and desilencing at sites other than rDNA loci. Levels of Ino1p mRNA are 23-fold higher in old versus young wt cells and 14-fold higher in old versus young sip2Delta cells (Table II). Previous studies of young cells (32) indicated that in the absence of glucose, Snf1-mediated phosphorylation of histone H3 regulates binding of the transcriptional activator Adr1p to its target gene promoters, leading to induction of ADH2 (ADHII isozyme that catalyzes the first step in ethanol metabolism), ACS1 (acetyl-CoA synthetase), and POT1 (3-oxoacyl-CoA thiolase) expression. Our GeneChip analysis disclosed that each of these mRNAs rises in aging wt and/or sip2Delta cells (Table II).


                              
View this table:
[in this window]
[in a new window]
 
Table II
GeneChip analysis of age-associated changes in expression of known Snf1 histone kinase targets

The Metabolic Shift Observed in sip2Delta Cells Also Occurs in sip2Delta fob1Delta Cells-- Snf1 promotes glycogen production by activating Glc7p, a protein phosphatase that activates glycogen synthase (33). We found that the rapid-aging phenotype of sip2Delta cells is associated with a metabolic shift toward gluconeogenesis and glycogen storage (23). This shift is also a natural consequence of aging. Wt cells accumulate glycogen as they undergo replicative senescence; the increase is equivalent to that observed in sip2Delta cells that have traversed an equivalent percentage of their mean generational life span (Fig. 7A).


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 7.   fob1Delta rescues the rapid-aging phenotype of sip2Delta cells without affecting the age-associated shift toward glucose storage. A, glycogen concentrations in generation 0-1 and generation 7-8 wt, sip2Delta , fob1Delta , and sip2Delta fob1Delta cells recovered from YPD medium by magnetic bead sorting. Generation 18-21 cells were harvested by micromanipulation directly from YPD/agar plates (n = 59 cells assayed). B, fructose 1,6-bisphosphatase levels. C, total cellular NAD+ concentrations. Mean values ± S.E. are plotted (n = three to six independent determinations for sorted populations, each in duplicate).

We had speculated that the shift toward gluconeogenesis, glucose storage, and energy conservation may be a mediator as well as a marker of aging since it was forestalled in longer-lived snf4Delta cells. The extended life span of the sip2Delta fob1Delta strain allowed us to explore this hypothesis further.

Populations of sorted generation 0-1 and 7-8 cells were prepared from isogenic wt, sip2Delta , fob1Delta , and sip2Delta fob1Delta strains grown in YPD medium. Well established microanalytic biochemical assays (23) revealed that introduction of fob1Delta does not ameliorate the marked age-associated increase in fructose 1,6-bisphosphatase and glycogen levels prompted by sip2Delta , nor does it significantly change total cellular NAD+ levels (Fig. 7, A-C). In addition, pgm1Delta cells (phosphoglucomutase; converts glucose 6-phosphate to glucose 1-phosphate) have a normal life span (data not shown). We concluded that the metabolic shift toward gluconeogenesis is a marker but not necessarily a mediator of aging.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Our studies have revealed a mechanism that links the Snf1 glucose-sensing pathway in S. cerevisiae to modification of chromatin structure and aging. An age-associated increase in Snf1 histone H3 kinase activity occurs coincident with a shift in its beta  subunit from the plasma membrane to the cytoplasm and its activating gamma  subunit (Snf4p) from the plasma membrane to the nucleus. These shifts in subunit localization are accompanied by age-associated increases in recombination at rDNA loci (generating ERCs) and augmented desilencing at rDNA loci, telomeres, as well as sites known in younger cells to be affected by Snf1p-catalyzed phosphorylation of histone H3. Several observations established that N-myristoylated Sip2p is a key regulator of Snf1 in aging cells. Among the three genes encoding Snf1 beta  subunits (SIP1, SIP2, GAL83), only sip2Delta affects aging. The rapid-aging phenotype of sip2Delta cells is completely rescued by blocking recombination at rDNA loci with a fob1Delta allele. N-Myristoylation of Sip2p is essential for normal cellular life span. When the plasma membrane association of Sip2p is abolished by a mutation that blocks its N-myristoylation, Snf4p is shifted to the nucleus. Together, these findings are consistent with a model where Sip2p functions as a negative regulator of nuclear Snf1 activity in young cells by sequestering its activating gamma  subunit at the plasma membrane and where age-associated loss of Sip2p from the plasma membrane to the cytoplasm facilities Snf4p/Snf1p entry into the nucleus and Snf1-catalyzed modification of chromatin structure.

beta subunits play a key role in mediating the diverse functions of Snf1 in younger cells. Snf1p is not functional in strains that lack all three subunits (16). Sip2p and Gal83p are required for growth on glycerol/ethanol, a poor carbon source that mimics low glucose (16). Sip1p appears to be involved in the dephosphorylation of Sip4p, a transcription factor that binds to carbon source-responsive elements present in genes encoding gluconeogenic enzymes (16, 34). Gal83p alone is required for phosphorylation of the same protein (16).

All beta  subunits have conserved C-terminal domains that mediate interactions with Snf1p and Snf4p (these domains are termed KIS and ASC, respectively) (35). The N termini of the three beta  subunits are more divergent than their C-terminal domains and contribute to their distinct intracellular locations and functions. Sip1p is found in the vacuole when cells are grown in glycerol (27). In contrast, Gal83p moves from the cytoplasm to the nucleus when cells are shifted from glucose to glycerol (27). The N-terminal 90 residues of Gal83p are sufficient to confer nuclear localization (27). Sip2p is the only Snf1 beta  subunit that is N-myristoylated and, as noted above, is affiliated with the plasma membrane. (The beta  subunit of the mammalian Snf1 homolog, AMPK, is also predicted to be a substrate for N-myristoyltransferase) (14).

The importance of N-myristoylation of Sip2p in modulating cellular life span is highlighted by two findings. First, the accelerated aging phenotype of sip2Delta cells can be fully rescued by a CEN episome containing SIP2 under the control of its own promoter but not by an episome containing a sip2 mutant with a Gly1 right-arrow Ala substitution that blocks N-myristoylation. Second, a strain containing a mutant nmt1 allele that produces global defects in protein N-myristoylation (nmt1-451D) has a rapid-aging phenotype (22). The mean life spans of isogenic nmt1-451D and nmt1-451Dsip2Delta strains are the same. In addition, introducing null alleles of genes encoding a number of prominent N-myristoylproteins into wt cells has no effect on life span (22). Together, these observations suggest that loss of myristoylSip2p is the principal contributor to the rapid aging of nmt1-451D cells.

We know that the trigger to Snf1 activation in aging cells is not a reduction in intracellular glucose levels; they rise 2- and 8-fold as wt and sip2Delta cells go from generation 0-1 to 7-8, respectively (23). Impaired glucose transport does not appear to be the trigger: transport rates rise modestly in aging cells as judged by the uptake of 2-deoxyglucose (22). Although one possible trigger could be an age-associated change in the level of N-myristoylation of Sip2p, to date we have no evidence to support such a notion. Our GeneChip analysis revealed that Nmt1p mRNA levels were not appreciably different in young and old wt and sip2Delta cells, nor were there detectable changes in expression of genes that regulate myristoyl-CoA pool size, e.g. FAA1-4 (fatty acyl-CoA synthetases) and FAS1,FAS2 (fatty acid synthetases) (data not shown). A sensitive assay for Nmt1p activity (36) could not be used to directly measure enzyme activity in unfractionated lysates prepared from young and old cells because of the high background. However, immunoblot analysis of total cellular proteins using previously characterized antibodies to Nmt (37) revealed no apparent differences in enzyme concentration between young and old wt or sip2Delta cells (data not shown).

It is important to note that for many N-myristoylproteins myristate is a key but not an exclusive regulator of membrane association. Protein N-myristoylation promotes weak and reversible protein-membrane interactions (38). Proteins such as myristoylated alanine-rich C kinase substrate use myristate plus electrostatic interactions between positively charged protein side chains and negatively charged phospholipids to stabilize their association with the plasma membrane (39). Phosphorylation of these side chains functions is used to sever the association (39). Other N-myristoylproteins such as ADP-ribosylation factors or recoverin use ligand binding to produce a conformational change that exposes or sequesters their myristoyl chain ("myristoyl-conformational switch") (40, 41). Thus, the age-associated redistribution of Sip2p from the plasma membrane to the cytoplasm could reflect changes in its levels of N-myristoylation or reversible modifications that affect electrostatic interactions with membrane phospholipids and/or a conformation change triggered by acquisition of a ligand that affects presentation of its myristoyl group. Distinguishing among these possibilities should provide further mechanistic details about how Snf1p is activated in aging cells and how such activation can be overcome.

    ACKNOWLEDGEMENTS

We thank our colleagues Mark Johnston, Shin Imai, James Dover, and Jeff Polish for valuable discussions and suggestions, Shelley Berger for generously providing samples of the histone H3 peptide and its phospho-Ser10 derivative, and Marian Carlson for kindly supplying plasmids expressing Snf1 subunit-GFP fusion proteins.

    FOOTNOTES

* This work was supported in part by National Institutes of Health Grant AI38200 and the American Federation for Aging Research.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Dept. of Molecular Biology and Pharmacology, Box 8103, Washington University School of Medicine, 660 S. Euclid Ave., St. Louis, MO 63110. Tel.: 314-362-7243; Fax: 314-362-7047; E-mail: jgordon@molecool.wustl.edu.

Published, JBC Papers in Press, January 31, 2003, DOI 10.1074/jbc.M212818200

    ABBREVIATIONS

The abbreviations used are: ERC, extrachromosomal rDNA circle; wt, wild type; GFP, green fluorescent protein; Nmt1p, myristoyl-CoA:protein N-myristoyltransferase; AMPK, AMP-activated protein kinase.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Muller, I. (1971) Arch. Mikrobiol. 77, 20-25[Medline] [Order article via Infotrieve]
2. Smeal, T., Claus, J., Kennedy, B., Cole, F., and Guarente, L. (1996) Cell 84, 633-642[Medline] [Order article via Infotrieve]
3. Sinclair, D. A., Mills, K., and Guarente, L. (1997) Science 277, 1313-1316[Abstract/Free Full Text]
4. Defossez, P. A., Prusty, R., Kaeberlein, M., Lin, S. J., Ferrigno, P., Silver, P. A., Keil, R. L., and Guarente, L. (1999) Mol. Cell 3, 447-455[Medline] [Order article via Infotrieve]
5. Sinclair, D. A., and Guarente, L. (1997) Cell 91, 1033-1042[Medline] [Order article via Infotrieve]
6. Kobayashi, T., and Horiuchi, T. (1996) Genes Cells 1, 465-474[Abstract/Free Full Text]
7. Smith, J. S., and Boeke, J. D. (1997) Genes Dev. 11, 241-254[Abstract]
8. Kaeberlein, M., McVey, M., and Guarente, L. (1999) Genes Dev. 13, 2570-2580[Abstract/Free Full Text]
9. Imai, S., Armstrong, C. M., Kaeberlein, M., and Guarente, L. (2000) Nature 403, 795-800[CrossRef][Medline] [Order article via Infotrieve]
10. Anderson, R. M., Bitterman, K. J., Wood, J. G., Medvedik, O., Cohen, H., Lin, S. S., Manchester, J. K., Gordon, J. I., and Sinclair, D. A. (2002) J. Biol. Chem. 277, 18881-18890[Abstract/Free Full Text]
11. Tanner, K. G., Landry, J., Sternglanz, R., and Denu, J. M. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 1357-1361
12. Tanny, J. C., and Moazed, D. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 415-420[Abstract/Free Full Text]
13. Bitterman, K. J., Anderson, R. M., Cohen, H. Y., Latorre-Esteves, M., and Sinclair, D. A. (2002) J. Biol. Chem. 277, 45099-45107[Abstract/Free Full Text]
14. Hardie, D. G., Carling, D., and Carlson, M. (1998) Annu. Rev. Biochem. 67, 821-855[CrossRef][Medline] [Order article via Infotrieve]
15. Carlson, M. (1999) Curr. Opin. Microbiol. 2, 202-207[CrossRef][Medline] [Order article via Infotrieve]
16. Schmidt, M. C., and McCartney, R. R. (2000) EMBO J. 19, 4936-4943[Abstract/Free Full Text]
17. Celenza, J. L., and Carlson, M. (1986) Science 233, 1175-1180[Medline] [Order article via Infotrieve]
18. Celenza, J. L., and Carlson, M. (1989) Mol. Cell. Biol. 9, 5034-5044[Medline] [Order article via Infotrieve]
19. McCartney, R. R., and Schmidt, M. C. (2001) J. Biol. Chem. 276, 36460-36466[Abstract/Free Full Text]
20. Wilson, W. A., Hawley, S. A., and Hardie, D. G. (1996) Curr. Biol. 6, 1426-1434[Medline] [Order article via Infotrieve]
21. DeVit, M. J., and Johnston, M. (1999) Curr. Biol. 9, 1231-1241[CrossRef][Medline] [Order article via Infotrieve]
22. Ashrafi, K., Lin, S. S., Manchester, J. K., and Gordon, J. I. (2000) Genes Dev. 14, 1872-1885[Abstract/Free Full Text]
23. Lin, S. S., Manchester, J. K., and Gordon, J. I. (2001) J. Biol. Chem. 276, 36000-36007[Abstract/Free Full Text]
24. Lo, W. S., Duggan, L., Tolga, N. C., Emre, Belotserkovskya, R., Lane, W. S., Shiekhattar, R., and Berger, S. L. (2001) Science 293, 1142-1146[Abstract/Free Full Text]
25. Niedenthal, R. K., Riles, L., Johnston, M., and Hegemann, J. H. (1996) Yeast 12, 773-786[CrossRef][Medline] [Order article via Infotrieve]
26. Kennedy, B. K., Austriaco, N. R., Jr., Zhang, J., and Guarente, L. (1995) Cell 80, 485-496[Medline] [Order article via Infotrieve]
27. Vincent, O., Townley, R., Kuchin, S., and Carlson, M. (2001) Genes Dev. 15, 1104-1114[Abstract/Free Full Text]
28. Passoneau, J. V., and Lowry, O. H. (1993) Enzymatic Analysis: A Practical Guide , Humana Press, Totowa, NJ
29. Barbehenn, E. K., Law, M. M., Brown, J. G., and Lowry, O. H. (1976) Anal. Biochem. 70, 554-562[Medline] [Order article via Infotrieve]
30. Ashrafi, K., Farazi, T. A., and Gordon, J. I. (1998) J. Biol. Chem. 273, 25864-25874[Abstract/Free Full Text]
31. Farazi, T. A., Waksman, G., and Gordon, J. I. (2001) J. Biol. Chem. 276, 39501-39504[Free Full Text]
32. Young, E. T., Kacherovsky, N., and Riper, K. V. (2002) J. Biol. Chem. 277, 38095-38103[Abstract/Free Full Text]
33. Francois, J., and Parrou, J. L. (2001) FEMS Microbiol. Rev. 25, 125-145[CrossRef][Medline] [Order article via Infotrieve]
34. Lesage, P., Yang, X., and Carlson, M. (1996) Mol. Cell. Biol. 16, 1921-1928[Abstract]
35. Jiang, R., and Carlson, M. (1996) Genes Dev. 10, 3105-3115[Abstract]
36. Farazi, T. A., Manchester, J. K., and Gordon, J. I. (2000) Biochemistry 39, 15807-15816[CrossRef][Medline] [Order article via Infotrieve]
37. Lodge, J. K., Jackson-Machelski, E., Higgins, M., McWherter, C. A., Sikorski, J. A., Devadas, B., and Gordon, J. I. (1998) J. Biol. Chem. 273, 12482-12491[Abstract/Free Full Text]
38. Peitzsch, R. M., and McLaughlin, S. (1993) Biochemistry 32, 10436-10443[Medline] [Order article via Infotrieve]
39. McLaughlin, S., and Aderem, A. (1995) Trends Biochem. Sci. 20, 272-276[CrossRef][Medline] [Order article via Infotrieve]
40. Goldberg, J. (1998) Cell 95, 237-248[Medline] [Order article via Infotrieve]
41. Ames, J. B., Ishima, R., Tanaka, T., Gordon, J. I., Stryer, L., and Ikura, M. (1997) Nature 389, 198-202[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.